224 related articles for article (PubMed ID: 23898069)
21. [Antiproliferation of cardamonin associated with mRNA expression of mTOR, Raptor and Rictor].
Zheng W; Shi D; Ji X; Han Y; Liao Q
Zhongguo Zhong Yao Za Zhi; 2010 Sep; 35(17):2318-23. PubMed ID: 21137347
[TBL] [Abstract][Full Text] [Related]
22. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton.
Sarbassov DD; Ali SM; Kim DH; Guertin DA; Latek RR; Erdjument-Bromage H; Tempst P; Sabatini DM
Curr Biol; 2004 Jul; 14(14):1296-302. PubMed ID: 15268862
[TBL] [Abstract][Full Text] [Related]
23. mTOR is frequently active in GH-secreting pituitary adenomas without influencing their morphopathological features.
Sajjad EA; Zieliński G; Maksymowicz M; Hutnik Ł; Bednarczuk T; Włodarski P
Endocr Pathol; 2013 Mar; 24(1):11-9. PubMed ID: 23296986
[TBL] [Abstract][Full Text] [Related]
24. Proliferation, vascular endothelial growth factor expression and cavernous sinus invasion in growth hormone secreting pituitary adenomas.
Iuchi T; Saeki N; Osato K; Yamaura A
Acta Neurochir (Wien); 2000; 142(12):1345-51. PubMed ID: 11214627
[TBL] [Abstract][Full Text] [Related]
25. mTOR expression and activity patterns in gastroenteropancreatic neuroendocrine tumours.
Kasajima A; Pavel M; Darb-Esfahani S; Noske A; Stenzinger A; Sasano H; Dietel M; Denkert C; Röcken C; Wiedenmann B; Weichert W
Endocr Relat Cancer; 2011 Feb; 18(1):181-92. PubMed ID: 21159731
[TBL] [Abstract][Full Text] [Related]
26. Rictor regulates MMP-9 activity and invasion through Raf-1-MEK-ERK signaling pathway in glioma cells.
Das G; Shiras A; Shanmuganandam K; Shastry P
Mol Carcinog; 2011 Jun; 50(6):412-23. PubMed ID: 21557327
[TBL] [Abstract][Full Text] [Related]
27. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A;
Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of magnetic resonance imaging criteria for cavernous sinus invasion in patients with pituitary adenomas: logistic regression analysis and correlation with surgical findings.
Vieira JO; Cukiert A; Liberman B
Surg Neurol; 2006 Feb; 65(2):130-5; discussion 135. PubMed ID: 16427401
[TBL] [Abstract][Full Text] [Related]
29. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
[TBL] [Abstract][Full Text] [Related]
30. Endocrinological outcome following first time transsphenoidal surgery for GH-, ACTH-, and PRL-secreting pituitary adenomas.
Kristof RA; Schramm J; Redel L; Neuloh G; Wichers M; Klingmüller D
Acta Neurochir (Wien); 2002 Jun; 144(6):555-61; discussion 561. PubMed ID: 12111488
[TBL] [Abstract][Full Text] [Related]
31. Defining the Domain Arrangement of the Mammalian Target of Rapamycin Complex Component Rictor Protein.
Zhou P; Zhang N; Nussinov R; Ma B
J Comput Biol; 2015 Sep; 22(9):876-86. PubMed ID: 26176550
[TBL] [Abstract][Full Text] [Related]
32. Phosphorylated 4E-binding protein 1 (p-4E-BP1): a novel prognostic marker in human astrocytomas.
Korkolopoulou P; Levidou G; El-Habr EA; Piperi C; Adamopoulos C; Samaras V; Boviatsis E; Thymara I; Trigka EA; Sakellariou S; Kavantzas N; Patsouris E; Saetta AA
Histopathology; 2012 Aug; 61(2):293-305. PubMed ID: 22690797
[TBL] [Abstract][Full Text] [Related]
33. Expression of serine proteases and metalloproteinases in human pituitary adenomas and anterior pituitary lobe tissue.
Knappe UJ; Hagel C; Lisboa BW; Wilczak W; Lüdecke DK; Saeger W
Acta Neuropathol; 2003 Nov; 106(5):471-8. PubMed ID: 12904990
[TBL] [Abstract][Full Text] [Related]
34. Expression of metastasis-associated gene-1 is associated with bone invasion and tumor stage in human pituitary adenomas.
Jia W; Zhu J; Martin TA; Sanders AJ; Yang X; Cheng S; Yu H; Jia G; Liu X; Lu R; Jiang WG
Cancer Genomics Proteomics; 2015; 12(3):113-8. PubMed ID: 25977170
[TBL] [Abstract][Full Text] [Related]
35. The relation of pituitary adenomas invasiveness and the proliferative index measured by immunoexpression of topoisomerase IIα.
Kwinta BM; Wilk A; Trofimiuk-Muldner M; Grzywna E; Krzyżewski RM; Stachura K; Adamek D
Endokrynol Pol; 2018; 69(5):530-535. PubMed ID: 30074233
[TBL] [Abstract][Full Text] [Related]
36. mTORC2 activity is elevated in gliomas and promotes growth and cell motility via overexpression of rictor.
Masri J; Bernath A; Martin J; Jo OD; Vartanian R; Funk A; Gera J
Cancer Res; 2007 Dec; 67(24):11712-20. PubMed ID: 18089801
[TBL] [Abstract][Full Text] [Related]
37. Metalloproteinases ADAM12 and MMP-14 are associated with cavernous sinus invasion in pituitary adenomas.
Wang J; Voellger B; Benzel J; Schlomann U; Nimsky C; Bartsch JW; Carl B
Int J Cancer; 2016 Sep; 139(6):1327-39. PubMed ID: 27144841
[TBL] [Abstract][Full Text] [Related]
38. Analysis of the growth rate and cavernous sinus invasion of pituitary adenomas.
Kawamoto H; Uozumi T; Kawamoto K; Arita K; Yano T; Hirohata T
Acta Neurochir (Wien); 1995; 136(1-2):37-43. PubMed ID: 8748825
[TBL] [Abstract][Full Text] [Related]
39. Clinical and histological correlations in prolactinomas, with special reference to bromocriptine resistance.
Delgrange E; Sassolas G; Perrin G; Jan M; Trouillas J
Acta Neurochir (Wien); 2005 Jul; 147(7):751-7; discussion 757-8. PubMed ID: 15971099
[TBL] [Abstract][Full Text] [Related]
40. [Prognostic value of the Knosp scale in trans-sphenoidal surgery for pituitary adenomas].
Zieliński G; Podgórski JK
Neurol Neurochir Pol; 2002; 36(1):69-82. PubMed ID: 12053617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
